This study of the efficacy and safety of Plecanatide in children 6 to \<18 Years of Age with Irritable Bowel Syndrome with Constipation (IBS-C)
Irritable Bowel Syndrome With Constipation
This study of the efficacy and safety of Plecanatide in children 6 to \<18 Years of Age with Irritable Bowel Syndrome with Constipation (IBS-C)
Efficacy and Safety of Plecanatide in Children 6 to <18 Years of Age With Irritable Bowel Syndrome With Constipation (IBS-C)
-
Synergy Research Site, Corona, California, United States, 92879
Synergy Research Site, Doral, Florida, United States, 33122
Synergy Research Site, Hialeah, Florida, United States, 33012
Synergy Research Site, Miami, Florida, United States, 33134
Synergy Research Site, Miami, Florida, United States, 33136
Synergy Research Site, Miami, Florida, United States, 33155
Synergy Research Site, Tampa, Florida, United States, 33607
Synergy Research Site, Crowley, Louisiana, United States, 70526
Synergy Research Site, Houston, Texas, United States, 77061
Synergy Research Site, San Antonio, Texas, United States, 78215
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
6 Years to 17 Years
ALL
No
Bausch Health Americas, Inc.,
John Lahey, STUDY_DIRECTOR, Bausch Health
2023-12